Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Targeted therapies and immune checkpoint inhibitors in the treatment of metastatic melanoma patients: a guide and update for pathologists — Hojabr Kakavand (2016) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Targeted therapies and immune checkpoint inhibitors in the treatment of metastatic melanoma patients: a guide and update for pathologists
Shared by
Richard A Scolyer
Targeted therapies and immune checkpoint inhibitors in the treatment of metastatic melanoma patients: a guide and update for pathologists
Article
2016
en
Authors
+1 more
HK
Hojabr Kakavand
JW
James S. Wilmott
GL
Georgina V. Long
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2019
The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors
Julia Lai‐Kwon
,
Chloe Khoo
,
Serigne Lo
,
Donna Milne
,
Mustafa Abdi Mohamed
,
Jeanette Raleigh
,
Kortnye Smith
,
Karolina Lisy
,
Shahneen Sandhu
,
Michael Jefford
Article
2018
The survivorship experience of patients with metastatic melanoma on long-term immune checkpoint inhibitors
Julia Lai‐Kwon
,
Christine Khoo
,
Serigne Lo
,
Donna Milne
,
Mustafa Abdi Mohamed
,
Jeanette Raleigh
,
Kortnye Smith
,
Karolina Lisy
,
Shahneen Sandhu
,
Michael Jefford
Article
2017
Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
Tuba N. Gide
,
James S. Wilmott
,
Richard A Scolyer
,
Georgina V. Long
Preprint
2023
Data from Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
Tuba N. Gide
,
James S. Wilmott
,
Richard A Scolyer
,
Georgina V. Long
Preprint
2023
Data from Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
Tuba N. Gide
,
James S. Wilmott
,
Richard A Scolyer
,
Georgina V. Long
Discussion(0)
No comments yet. Be the first to comment.